首页> 外文期刊>Frontiers in Oncology >Activation of Epithelial-Mesenchymal Transition and Altered β-Catenin Signaling in a Novel Indian Colorectal Carcinoma Cell Line
【24h】

Activation of Epithelial-Mesenchymal Transition and Altered β-Catenin Signaling in a Novel Indian Colorectal Carcinoma Cell Line

机译:新型印度大肠癌细胞系中上皮-间质转化的激活和β-连环蛋白信号的改变

获取原文

摘要

Colorectal cancer is the third major cause of cancer-related mortality worldwide. The upward trend in incidence and mortality rates, poor sensitivity to conventional therapies and a dearth of early diagnostic parameters pose a huge challenge in the management of colorectal cancer in India. Due to the high level of genetic diversity present in the Indian population, unraveling the genetic contributions toward pathogenesis is key for understanding the etiology of colorectal cancer and in reversing this trend. We have established a novel cell line, MBC02, from an Indian colorectal cancer patient and have carried out extensive molecular characterization to unravel the pathological alterations in this cell line. In-depth molecular analysis of MBC02 revealed suppression of E-cadherin expression, concomitant with overexpression of EMT related molecules, which manifested in the form of highly migratory and invasive cells. Loss of membrane-tethered E-cadherin released β-catenin from the adherens junction resulting in its cytoplasmic and nuclear accumulation and consequently, upregulation of c-Myc . MBC02 also showed dramatic transcriptional upregulation of β-catenin. Remarkably, we observed significantly elevated proteasome activity that perhaps co-evolved to compensate for the unnaturally high mRNA level of β-catenin to regulate the increased protein load. In addition, there was substantial misregulation of other clinically relevant signaling pathways that have clinical relevance in the pathogenesis of colorectal cancer. Our findings pave the way toward understanding the molecular differences that could define pathogenesis in cancers originating in the Indian population.
机译:大肠癌是全世界与癌症相关的死亡率的第三大主要原因。发病率和死亡率的上升趋势,对传统疗法的敏感性差以及缺乏早期诊断参数对印度大肠癌的治疗提出了巨大挑战。由于印度人口中遗传多样性的高水平,弄清遗传学对发病机理的贡献是理解大肠癌病因和逆转这一趋势的关键。我们已经从印度大肠癌患者那里建立了一种新型的细胞系MBC02,并进行了广泛的分子表征以揭示该细胞系的病理变化。 MBC02的深入分子分析显示,E-钙粘着蛋白表达受到抑制,与EMT相关分子的过表达相伴,以高度迁移和侵袭性细胞的形式表现出来。膜连接的E-钙粘着蛋白的损失从粘附连接处释放β-连环蛋白,导致其胞质和核积累,因此,c-Myc上调。 MBC02还显示了β-catenin的显着转录上调。值得注意的是,我们观察到蛋白酶体活性显着升高,可能共同进化以补偿β-catenin异常高的mRNA水平,从而调节增加的蛋白质负荷。此外,在结直肠癌的发病机理中具有临床相关性的其他临床相关信号通路也存在严重失调。我们的发现为理解可能定义起源于印度人群的癌症的发病机制的分子差异铺平了道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号